| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |